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Abstract
Anxiety disorders are among the most common youth mental health disorders. Early intervention can reduce elevated anxiety 
symptoms. School-based interventions exist but it is unclear how effective targeted approaches are for reducing symptoms 
of anxiety. This review and meta-analysis aimed to determine the effectiveness of school-based indicated interventions 
for symptomatic children and adolescents. The study was registered with PROSPERO [CRD42018087628]. We searched 
MEDLINE, EMBASE, PsycINFO, and the Cochrane Library for randomised-controlled trials comparing indicated programs 
for child and adolescent (5–18 years) anxiety to active or inactive control groups. Data were extracted from papers up to 
December 2019. The primary outcome was efficacy (mean change in anxiety symptom scores). Sub-group and sensitivity 
analyses explored intervention intensity and control type. We identified 20 studies with 2076 participants. Eighteen studies 
were suitable for meta-analysis. A small positive effect was found for indicated programs compared to controls on self-
reported anxiety symptoms at post-test (g = − 0.28, CI = − 0.50, − 0.05, k = 18). This benefit was maintained at 6 (g = − 0.35, 
CI = − 0.58, − 0.13, k = 9) and 12 months (g = − 0.24, CI = − 0.48, 0.00, k = 4). Based on two studies, > 12 month effects were 
very small (g = − 0.01, CI = − 0.38, 0.36). No differences were found based on intervention intensity or control type. Risk 
of bias and variability between studies was high (I2 = 78%). Findings show that school-based indicated programs for child 
and adolescent anxiety can produce small beneficial effects, enduring for up to 12 months. Future studies should include 
long-term diagnostic assessments.
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Introduction
Globally, approximately 117 million children and young 
people are affected by anxiety disorders [1]. Fewer than 
20% of young people with anxiety disorder access support 
[2], and of those that do, a significant minority end treat-
ment prematurely or do not benefit [3, 4]. Cost-effective-
ness analyses indicate that treatment alone is insufficient 
to eliminate the disease burden of these disorders and that 
investment in prevention and early intervention are needed 
[5]. Evidence-based prevention, early intervention and treat-
ment approaches exist for anxiety [6] with broadly similar 
content, only differing substantively in terms of the time 
point at which they are delivered [7]. Elevated anxiety symp-
toms affect quality of life and are a risk factor for anxiety 
disorders. The reduction of elevated symptoms is there-
fore important to improve functioning and well-being, and 
to potentially prevent new cases of disorder. Schools are 
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considered good sites for early intervention programs given 
their reach and circumventing of common barriers to support 
[8]. Programs can be universal (delivered to all pupils) or 
targeted, being either selective (delivered to those at higher 
risk, based, for example, on family history), or indicated 
(delivered to those with detectable but sub-clinical symp-
toms) [9]. Most studies evaluate interventions in terms of 
their impact on anxiety symptoms rather than diagnostic out-
comes, possibly due to the resource requirements for diag-
nostic assessments. It is unclear which delivery approach is 
most effective for reducing symptoms of anxiety and which 
should be implemented in schools.
Meta-analyses have reviewed the effects of different 
delivery formats. Interpretations of the value of reported 
effect sizes (ES) from this body of work need to consider a 
number of factors [10]. For example, the importance of an 
effect can depend on intervention costs, ease of delivery, 
scale-up penalties, school attendance and academic/social 
benefits, changes in health care utilisation, numbers of new 
cases averted and spill over effects to peers [10]. Small ES 
from relatively inexpensive, scalable interventions (e.g., in 
schools where the infrastructure exists), that reach large sec-
tions of the population at a time of vulnerability to mental 
health disorder could have substantial practical importance, 
considering the high prevalence of anxiety, its psychosocial 
and economic impact, and that so few young people access 
support via other means [2].
Most school-based anxiety interventions to date have 
been universal and highly heterogeneous. Meta-analyses of 
these report small-to-moderate post-test ES in the range of 
0.2–0.5 on anxiety symptoms in children and adolescents 
[11–20]. Although 12 month effects from universal pro-
grams have been reported for depressive symptoms [10, 21], 
similar outcomes from universal programs for anxiety symp-
toms are rare, with only a few studies reporting ES span-
ning small, marginal, or no effects at 12 and/or 24 months 
[12, 14–17, 19, 20]. Targeted approaches for depression, 
delivered in school to at-risk young people, appear more 
effective than universal approaches, suggesting that interven-
tion effectiveness increases with symptom severity [21, 22] 
However, findings from studies of targeted approaches to 
reduce anxiety symptoms are mixed. Lawrence, Rooke, and 
Creswell’s (2017) meta-analysis of 16 RCTs, which merged 
indicated and selective trials, reported a significant small-
to-moderate effects (ES = − 0.43) on post-test anxiety symp-
toms compared to waitlist controls (k = 10) but only a very 
small non-significant effect compared to attention controls 
(ES = − 0.09, k = 5) [15]. Effects increased up to 6 months 
but fell at 12 and 24 months.
Two reviews have compared universal and targeted pro-
gram effectiveness. Merging studies of indicated and selec-
tive interventions, Teubert and Pinquart’s (2011) review of 
65 trials (where anxiety symptoms or diagnostic status was 
a primary or secondary outcome) found that, at post-test, tar-
geted programs (k = 36 studies) were associated with a sig-
nificantly higher mean ES (0.32) than universal programs 
(0.12), although this difference was no longer significant at 
follow-up (0.15 for universal and 0.23 for indicated) (0.23) 
[17]. In comparison, Werner-Seidler et al.’s (2017) review of 
81 original randomised-controlled trials (RCTs), which also 
merged indicated and selective programs, found no signifi-
cant differences in ES between these and universal programs 
for anxiety symptoms across all ages in the short, medium, 
or long terms [20]. Some targeted approaches performed no 
better than universal approaches in the short term or long 
term. In sum, reviews have produced mostly small post-test 
ES for targeted approaches. However, the merging of selec-
tive and indicated trials in these reviews is problematic as 
the former targets asymptomatic young people and the latter 
targets those with detectable elevated symptoms. Indicated 
interventions have the potential to be more effective than 
selective interventions given the scope for change in symp-
toms, and the targeting of especially responsive groups who 
are motivated to engage in the intervention [10]. To date, 
only one review has isolated the effect of school indicated 
interventions for reducing symptoms of anxiety. Neil and 
Christensen’s (2009) review of 27 trials (published between 
1987 and 2008) spanned universal (k = 16), indicated (k = 8), 
and selective (k = 3) programs for 5–19 year olds [16]. At 
post-test, 69% of the universal programs (k = 11) reported 
significant differences between the intervention and con-
trol conditions at post-test, with moderate-to-very large ES 
(0.31–1.37). This compared to only 50% of indicated trials 
(k = 4) with small-to-moderate ES (0.20–0.76). At follow-
up, however, indicated trials outperformed universal pro-
grams. Out of six indicated trials that reported follow-up 
data (spanning 1–30 months), all but one (83%) reported 
significant small-to-large effects (0.19–1.03). Out of the six 
trials of universal programs with follow-up data, 3 (50%) 
reported significant small-to-moderate effects (0.22–0.70). 
Thus, compared to universal programs, a higher proportion 
of indicated programs secured long-term symptom reduc-
tion, and some with larger effects (although the difference 
was not formally tested). However, the number of indicated 
trials was low and the quality poor.
A number of new trials of school indicated approaches 
for reducing anxiety symptoms have been conducted since 
Neil and Christensen [16]. Producing an updated ES for 
indicated school programs will progress the evidence for 
effective early intervention strategies for symptom reduc-
tion that can be delivered at a population level. The aim of 
our review was to (1) synthesise evidence on school indi-
cated programs for reducing elevated (sub-clinical) anxiety 
symptoms in children and adolescents; (2) conduct a meta-
analysis to identify their overall effects; (3) establish the 
duration of any effects; and (4) determine the relative effect 
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of interventions according to control type, delivery agent, 
and intervention intensity.
Methods
Data sources and searches
We searched MEDLINE, EMBASE, PsycINFO, and the 
Cochrane Central Register of Controlled Trials, Clinical-
Trials.gov, and PROSPERO from database inception to 
December 2019. Details of search strategies are provided in 
Suppl. Table 1. Grey literature was searched using Google 
Scholar. Reference lists of relevant studies and reviews 
were searched. Study authors were contacted in the case 
of missing or ambiguous information. The review proto-
col was developed using the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) state-
ment guidelines [23] and was registered with PROSPERO 
[CRD42018087628 https ://www.crd.york.ac.uk/prosp ero/
displ ay_recor d.php?Recor dID=87628 ].
Study selection
Studies were eligible for this review if they were published 
in English and met the following PICOS inclusion criteria: 
(P) Population children/adolescents aged 5–18 years with 
elevated levels of anxiety. Studies with both sub-clinical 
and (likely or confirmed) clinical populations were included 
only where the intervention aim was described as preven-
tative rather than treatment. This decision accommodated 
any small variability in screening or diagnostic outcomes 
within a study, and the fact that many studies reported only 
symptom thresholds for inclusion and not upper thresholds 
for exclusion.
(I) Intervention school-based indicated prevention or 
early intervention programs for anxiety disorders, where 
school-based means endorsed by schools and delivered on 
school premises either face-to-face or online. Multi-tiered 
interventions were included if they contained an indicated 
intervention. Although our published protocol stated that 
we would include interventions that targeted depression and 
anxiety, Werner-Siedler et al. [20] recently reviewed indi-
cated programmes for depression; hence, we then restricted 
our review to interventions for anxiety. (C) Comparator pas-
sive comparators (waitlist and no intervention) and active 
comparators (programs to control for non-specific aspects of 
anxiety treatment). (O) Outcome anxiety symptoms meas-
ured via validated self-rating or clinician-rated scales and/
or diagnostic outcomes (i.e., no longer meeting diagnostic 
thresholds showing symptom reduction). (S) Study design 
randomised-controlled trials.
Outcome measures
Our main outcome was reduction of anxiety symptoms and 
prevention of anxiety disorder progression, i.e., a change in 
symptoms that could represent prevention of disorder. Our 
primary outcome for efficacy was the mean change scores 
on anxiety symptoms in comparison to controls, based on 
self-rating or clinician-rated scales. Table 1 shows the pri-
mary outcome measures utilised in each study and included 
the Revised Children’s Anxiety and Depression scale [24], 
the Spence Children’s Anxiety Scale [25], the Revised Chil-
dren’s Manifest Anxiety Scale [26], the Screen for Child 
Anxiety Related Disorders [27], the State-Trait Anxiety 
Inventory [28], the Multidimensional Anxiety Scale for 
Children [29], the Child Behaviour Checklist [30], and the 
Social Phobia subscale [31]. Where a trial included more 
than one scale for anxiety symptoms, we used the scale with 
the greatest frequency across studies. Change in anxiety 
symptoms was also assessed in some studies via diagnostic 
interviews.
Screening, data extraction, and quality assessment
Three authors (SB and PM) and a medical student (inde-
pendent of study) separately screened the titles and abstracts 
of studies against the inclusion criteria in the first round of 
searching (up to September 2018). In the updated search (up 
to December 2019), abstracts were separately screened by 
two authors (PM, ET). Independent full-text reviews were 
completed by SB and PM (first search) and ET, PM and SHJ 
(updated search). Studies were included if they met all of the 
inclusion criteria. Disagreements between reviewers were 
resolved through discussion. For the included studies, data 
were extracted, using a Cochrane data abstraction form, by 
one investigator (SB) and were independently checked by 
another (PM). Data extracted included study details (author, 
publication year, and country), participant details (age range, 
gender, sample size, and school type), methodology (design, 
unit of allocation), intervention characteristics (type, con-
tent, target, provider, parental involvement, frequency, dura-
tion, and indicators of acceptability), control group (type), 
and all reported outcomes (definition, time points, person 
measuring, summary estimates, fidelity, acceptability, and 
compliance). For the waitlist control studies, follow-up data 
were only extracted if the waitlist control group remained 
waitlist at follow-up. Risk of bias was assessed with the 
Cochrane Handbook Risk of Bias Assessment Tool [32]. 
Risk of bias was assessed independently by one investigator 
(SB) and a medical student, neither of whom were blinded to 
the review aim. As recommended by Cochrane, risk of bias 
was reported separately for each of the seven criteria, namely 
random sequence generation, adequate concealment of this 
sequence, blinding of participants/personnel, blinding of 
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Table 1  Characteristics of included trials (k = 20) by date of publication
Mode of delivery: MHP Mental health professional, Grad graduate students. Program content: CBT Cognitive behavioural therapy, MBCT-C 
mindfulness-based cognitive therapy for children, WM working memory, ERT + HRV emotion regulation training and heart rate variability. Con-
trol: WL wait list, NI no intervention, AC attention control. Anxiety outcome measures: RCADS Revised Children’s Anxiety and Depression 
scale, SCAS Spence Children’s Anxiety Scale, RCMAS Revised Children’s Manifest Anxiety Scale, SCARED The Screen for Child Anxiety-
Related Disorders), STAI A-TRAIT State-Trait Anxiety Inventory, MAS Multidimensional Anxiety Scale for Children, CBCL Child Behaviour 
Checklist, SP subscale Social Phobia subscale. Follow-up effect sizes: NA not available (typically as waitlist controls had started the intervention 
by follow-up, so no true control group data available)
*Negative effect sizes indicate reduction in symptoms
a Excluded from the meta-analysis
b Also administered post-intervention diagnostic interviews
c Significant differences in anxiety scores between intervention and control groups
Trial citation Program N
Age (years)
Control Delivery Content Primary anxiety 
measure
Post-test effect 
size*
Follow-up 
effect size 
(months)
Kiselica et al. 
[41]
Stress inocula-
tion
48
14–15
NI MHP + school MHP CBT STAI A-TRAIT − 0.74a − 1.01 (1)c
Dadds et al. [36] Coping koala 128
7–14
NI MHP + Grad CBT RCMAS 0.01 − 0.05 (6)
Mifsud and 
Rapee [51]
Cool kids 91
8–11
WL MHP + school MHP CBT SCAS − 0.35 − 0.57 (4)c
Bernstein et al. 
[34, 54]
FRIENDS
(child + parent)
61
7–11
FRIENDS child 
only + WL
MHP + Grad CBT MASCb 0.22 − − 0.04 (6)
Gillham et al. 
[39]
Penn resiliency 
program
44
11–13
NI Grad/
researchers
CBT RCMAS − 0.07 − 0.62 (6)c
− 0.79 (12)c
Siu [47] FRIENDS 47
7–10
WL MHP CBT SCARED − 1.48a NA
Hunt et al. [38]a FRIENDS 260
11–13
NI School 
MHP + Teacher
CBT SCAS No control 
group data
0.17 (24)
− 0.01 (48)
Siu [48] Theraplay 46
Mean 7.8
WL MHP Play therapy Internalis-
ing scale of 
CBCL
− 2.40a NA
Manassis et al. 
[37]
Feelings club 148
8–12
AC MHP + Grad CBT MASCb − 0.06 − 0.06 (12)
Liddle and Mac-
millan [43]a
FRIENDS 51
8–14
WL MHP CBT SCAS No control 
group data
NA
Cooley-Strick-
land et al. [35]
FRIENDS 93
8–12
WL MHP + Grad CBT RCMAS 0.21 NA
Miller et al. [52] FRIENDS 191
9–12
AC Teacher + MHP/Grad CBT MASC 0.08 NA
Nobel et al. [45] Feelings Club 78
8–11
AC MHP CBT MASC 0.03 NA
McLoone and 
Rapee [44]
Cool Kids 152
7–12
Home + WL School MHP CBT SCAS − 0.43 − 0.27 (12)
Sportel et al. 
[33]; de Hullu 
et al. [55]
Cognitive 
Behavioural 
Group
240
12–16
CBT + NI MHP CBT SP subscale of 
 RCADSb
0.16 − 0.41 (6)c
− 0.17 (12)
− 0.21 (24)
Yulei et al. [50] Cool Kids 59
14–17
WL MHP + Grad CBT SCAS − 0.45 NA
Hadwin et al. 
[40]
Cogmed-WM 40
11–14
AC Computerised WM training RCMAS − 0.46 0.00 (3)
Lam [42] MBCT-C 20
9–13
WL MHP + Grad Mindfulness RCADS 0.22 NA
Scholten et al. 
[46]
Dojo video 
game
138
11–15
AC Computer-
ised + researcher
ERT + HRV 
biofeedback
SCAS − 0.11 0.03 (3)
Van Starrenburg 
et al. [49]
Coping Cat 141
7–13
WL MHP + Grad CBT SCAS − 0.58a − 0.64 (3)c
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outcome assessment, reporting of incomplete outcome data, 
selective reporting of data, and protection against contami-
nation. All domains were scored as (1) low risk of bias, (2) 
unclear, or (3) high risk of bias. Disagreement was resolved 
through discussion. Study quality was rated high risk study 
where three or more criteria showed high risk of bias, as low 
risk where five or more items rates showed low risk of bias, 
and as moderate risk in all remaining situations.
Statistical analysis
A meta-analysis using a random-effects model was con-
ducted (using the RevMan software version 5.3) as consider-
able heterogeneity was expected across studies. The inverse 
variance method was used to weight studies. Continuous 
outcomes are presented as standardised ES. Standardised 
ES estimates, referring to the difference between the inter-
vention and control group at post-intervention and follow-
up, were calculated using Hedge’s g (with 95% confidence 
intervals), which includes an adjustment for small-sample 
sizes. Negative ES indicate a decrease, and positive ES 
indicate an increase, in mean levels of anxiety symptoms 
between time points of comparison. The I2 statistic was used 
to test for homogeneity of ES by indicating heterogeneity 
in percentages, with 25%, 50%, and 75% representing low, 
moderate, and high heterogeneity, respectively. Sub-group 
analyses were conducted for delivery agent, control type, and 
intervention intensity. Sensitivity analyses were conducted 
using only studies with a low risk of bias. A funnel plot 
was used to assess for small-study effects and publication 
bias. Egger’s tests were conducted where asymmetry was 
apparent on visual inspection. Duval and Tweedie’s trim-
and-fill procedure was conducted using the Comprehensive 
Meta-Analysis software (version 3.0 Biostat Inc.) to give an 
adjusted estimate of unbiased ES.
Results
Study selection and characteristics
The PRISMA flow diagram (see Fig. 1) details the study-
selection process. In total, 2813 studies were identified, 
of which 266 were duplicates and removed, leaving 2547 
studies for title and abstract screening, following of which 
2421 studies were excluded leaving 126 studies for full-
text screening. Of these, 103 were excluded. Reasons for 
exclusion were dissertations; duplicates; not an indicated 
intervention; wrong population; not anxiety; treatment not 
prevention; not RCT; not school-based; different interven-
tion; and still recruiting. This left 23 studies for inclusion, 
of which 20 were original studies.
Characteristics of study samples, intervention, delivery 
agent, control type, and primary anxiety measure are shown 
in Table 1. The 20 reviewed studies included 2076 partici-
pants. All studies targeted generalised or unspecified anxiety 
except for one [33] which focused on social and test anxi-
ety. Four studies (20%) used diagnostic screening interviews 
that led to the inclusion of children who met both clinical 
and sub-clinical thresholds for anxiety disorder [33–36]. We 
included these as the interventions still had a preventive pur-
pose for those not meeting clinical thresholds. The remain-
ing 16 studies (80%) used self, parent, or teacher report to 
screen for baseline elevated anxiety symptoms. Screening 
tools and cut-off scores used to determine inclusion varied 
across studies. Whilst most studies utilised standardized 
measures at outcome, six (30%) also utilised diagnostic 
interviews [33–38].
Studies randomised participants at the individual (k = 13; 
65%) [35, 39–50], group (k = 1; 5%) [37], and school levels 
(k = 6; 30%) [33, 34, 36, 38, 51, 52]. With one exception 
(which was computerised) [46], all programs were deliv-
ered to groups, and program sessions (ranging from 40 to 
90 min) were usually conducted weekly (k = 17; 85%) [34, 
36–45, 47–52], also twice weekly (k = 2; 10%) [33], [46] 
or biweekly (k = 1; 5%) [35]. Only two programs included 
booster sessions.[34, 38] One study delivered a booster 
package of intervention prompts to the families of the inter-
vention group children post-intervention [36]. Secondary 
outcomes included academic achievement [35][40, 41]and 
two studies also reported on intervention acceptability.[42, 
48] Of the 19 programs delivered face-to-face, only seven 
(37%) were subjected to fidelity assessments, using either 
independent ratings of audio or video recordings of the ses-
sions (k = 4; 21%) [37, 38, 42, 52] or had supervised ses-
sions (k = 3; 16%). [34, 36, 49] Of the ten studies (50%) 
that reported on compliance [33–36, 39, 40, 42, 44, 47, 51], 
all reported high completion rates with at least more than 
50% of participants attending more than 50% of the sessions. 
Drop out during the intervention was only clearly reported in 
12 studies, and ranged from no dropout to a drop out of 35% 
[32] (see Suppl. Table 1) for further study details including 
screening measures, nature of control conditions, number of 
parent and child sessions, and other indicators of compliance 
(session attendance and measure non-completion).
The risk of bias was high, although most studies had an 
unclear risk of selection bias due to inadequate reporting 
of the randomisation procedure. Risk of contamination was 
high in 14 studies (70%) (students randomised to groups 
within schools) and low in six studies (30%) (cluster ran-
domisation). Blinding of participants and personnel was 
difficult as most studies had a wait list or no intervention 
control group (k = 15; 75%). Blinding of outcome assess-
ment was not feasible in 14 studies (70%) as self and parent 
report outcome measures were used. Studies which included 
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an outcomes diagnostic interview generally had a low risk of 
detection bias as interviewers were blind to the participants’ 
group (k = 4; 20%). For attrition bias, the risk was gener-
ally low. Nearly all studies had an unclear risk of reporting 
bias. The inter-rater reliability between the two independ-
ent reviewers for each risk of bias domain was adequate 
(Cohen’s Kappa > 0.80 for all risk of bias domains) (see 
Suppl. Fig. 1).
Records identified by database 
searching (n= 2805) and 
reference lists /grey literature (n=8) 
(total n=2813)
Full text articles excluded 
(n=103):
dissertation (n = 7)
duplicates (n = 7)
not indicated (n = 13)
wrong population (n = 9)
not anxiety (n= 27)
treatment not prevention (n= 2)
not RCT (n = 16)
not school-based (n = 19)
different intervention (n=1)
still recruiting (n=2) 
Records excluded (n=2421)
Full-text articles assessed for 
eligibility (n=126)
Original RCTs included in the review  
(n=20)
Original RCTs included in the meta-
analysis (n=18)
Comparisons
8 CBT vs wait-list controls 
4 CBT vs no intervention 
controls
3 CBT vs attention controls
1 Play therapy vs wait-list 
controls
1 CBM vs CBT vs no 
intervention controls
1 MBCT vs wait-list controls
1 WM training vs attention 
controls
1 ERT + HRV biofeedback vs 
attention controls
Records after duplicates 
removed (n=2547) 
Fig. 1  Flow diagram of selection of studies for inclusion. CBT cognitive behavioural therapy, CBM cognitive bias modification, MBCT-C mind-
fulness-based cognitive therapy for children, WM working memory, ERT + HRV emotion regulation training and heart rate variability
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A meta-analysis was conducted on the 18 studies with 
sufficient data to compare post-test differences in anxiety 
symptoms between intervention and control groups (Liddle 
and Macmillan [43] and Hunt et al. [38]were excluded due 
to inadequate data). Three studies had more than one com-
parison group. Therefore, for McLoone and Rapee [44], the 
school-based not home-based treatment group was included; 
for Bernstein, Layne, Egan, and Tennison [34], the child-
only group was combined with the child + parent group to 
create a collapsed treatment group; and for Sportel, de Hullu, 
de Jong, and Nauta [33], we compared the CBT and no inter-
vention control group, and for Hadwin et al. (2016) [40], 
we compared CBT (active control) and working memory 
training (intervention).
Efficacy outcomes
The overall post-test ES for change in anxiety symptoms 
was g = − 0.28 (CI = − 0.50, − 0.05) with large heterogeneity 
(I2 = 78%) (k = 18). The ES for change in anxiety symptoms 
in the short term (0–6 months) was g = − 0.35 (CI = − 0.58, 
− 0.13) (k = 9), in the medium term (6–12 months) was 
g = − 0.24 (CI = − 0.48, 0.00) (k = 4) and in the long term 
(> 12 months) was g = − 0.01, CI = − 0.38, 0.36) (k = 2). 
Significant post-test differences between intervention and 
control groups were reported in 4 out of 18 studies (22%) 
[41, 47–49] with medium-to-very large ES (based on Cohen 
[53]). At follow-up, significant medium-to-very large effects 
[10] were reported in 5 out of 11 studies with suitable data 
(46%).[33, 39, 41, 49, 51] Five of the eighteen trials (28%) 
reported small non-significant effects at either post-test or 
follow-up [34, 40, 44, 50][55]. Four trials (22%) failed to 
find any effect at either post-test or follow-up [34, 43, 44, 
54]. Findings from the four studies [35, 42, 45, 52] (and 
their follow-up publications) that reported post-test diagnos-
tic interviews at 12 and 24 m showed that the odds of having 
an anxiety disorder were significantly lower in the interven-
tion compared to the control group at 24 m (k = 2, OR = 0.40, 
95% CI = 0.19, 0.83) but not at 12 m (k = 2, OR = 0.64, 95% 
CI = 0.34, 1.18).
Sub‑group analyses
We could not perform a sub-group analysis on age (child 
vs adolescent) due to an insufficient number of studies that 
included children only (k = 4) and adolescents only (k = 3). A 
sub-group analysis could also not be performed on delivery 
agent (as very few interventions were delivered by teach-
ers, k = 2) nor on program type (most were CBT based). 
Figure 2 depicts a Forest plot of the ES for sub-group com-
parisons between intervention types and control conditions 
on post-test anxiety scores. The only pooled studies with 
significant, small effects were those comparing CBT to wait-
list (g = − 38).
No significant differences were found between control 
group type on the size of the effect  (Chi2 = 4.85, df = 2, 
P = 0.09, wait list: k = 9, g = − 0.53, 95% CI = − 0.97, 
− 0.09, attention control: k = 5, g = − 0.00, 95% CI = − 0.18, 
0.17, no intervention: k = 4, g = − 0.10, 95% CI = − 0.44, 
0.24). Finally, no significant differences were found based 
on intervention intensity (delivered weekly, biweekly or 
twice weekly) on post-test effect size  (Chi2 = 4.58, df = 2, 
P = 0.10; weekly: k = 15, g = − 0.32, 95% CI = − 0.59, 
− 0.06; biweekly: k = 1, g = 0.21, 95% CI = − 0.20, 0.62; 
twice weekly: k = 2, g = − 0.18, 95% CI = − 0.48, 0.13).
Sensitivity analyses
Sensitivity analyses were conducted on studies with a low 
risk of selection bias, a low risk of attrition bias, and a low 
risk of contamination (biases deemed most relevant to stud-
ies of this nature). Studies with a low risk of contamination 
had an ES of g = 0.03 (k = 5, 95% CI = − 0.14, 0.21). The ES 
for studies with a low risk of selection was g = − 0.21 (k = 4, 
95% CI = − 0.55, 0.13) and for studies with low attrition bias 
was g = − 0.35 (k = 11, 61% 95% CI = − 0.65, − 0.05). Funnel 
plot asymmetry (see Suppl. Fig. 2) suggested a small pub-
lication bias [Egger’s test: intercept: − 4.10 [95% CI − 7.59 
to 0.61], t = 2.49, P = 0.02. Results were improved when the 
Duval and Tweedie’s trim-and-fill method was used to adjust 
for funnel plot asymmetry (g was reduced from − 0.28 to 
− 0.08). However, this method has been shown to perform 
poorly where high heterogeneity exists between studies.
Discussion
Early intervention to reduce symptoms of anxiety is an 
increasing global priority [56]. To our knowledge, ours 
is the first review to produce an ES for indicated school-
based approaches for child and adolescent anxiety. We have 
addressed the limitations of previous meta-analyses which 
focused only on depression [12, 21, 22], mixed settings [12, 
15], and/or which merged selective and indicated interven-
tions [15, 17, 20]. We found an overall small post-test ES for 
anxiety symptom reduction of − 0.28 for intervention groups 
compared to controls. Large-to-very large effects at post-test 
were found in 22% of studies (k = 4) (− 0.58 to − 2.40) and 
at follow-up in 46% of studies (k = 5) (− 0.41 to − 1.01). 
Our findings are in line with Neil and Christensen [16]; 
although their data prohibited a formal meta-analysis, 50% 
(k = 4) of their reviewed trials produced significant small-
to-moderate post-test effects on anxiety symptoms ranging 
from 0.20–0.76. That five (28%) of our reviewed studies 
had a small but non-significant effect at either post-test or 
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follow-up suggests that lack of power may be masking fur-
ther potential positive effects.
Our post-test ES on anxiety symptoms is slightly smaller 
than those reported for universal programs [11–20]. How-
ever, concurring with Neil and Christensen [16], our review 
suggests that indicated programs may be more effective than 
universal programs over time. By 6 months, and based on 
nine studies, the post-test ES had increased from − 0.28 to 
− 0.35, suggesting that young people may take time to ben-
efit from programs. Four studies showed maintenance of a 
beneficial effect at 6–12 months (− 0.24), but this was no 
longer evident by > 12 months. This may be because only 
two studies had sufficient data beyond 12 months, and fur-
ther positive outcomes may have been missed as the studies 
with larger, significant post-test ES did not collect long-term 
outcomes [47, 48]. Good long-term outcomes were also 
evident in five studies in our review that utilised follow-up 
diagnostic interviews, and which found that the odds of hav-
ing an anxiety disorder at 12 and 24 months was lower in 
the intervention group compared to controls. Whilst this was 
non-significant at 12 months, the odds became significant 
at 24 months, suggesting that some indicated prevention 
programs can prevent the onset of disorder. Thus, whilst 
there were only a small number of studies collecting long-
term data from indicated programs, our review supports Neil 
and Christensen’s [16] finding that indicated programs can 
produce good medium-to-long-term outcomes for anxiety 
reduction in children and adolescents.
Our reviewed studies produced a range of ES at post-test 
and follow-up. Several factors may be driving this variabil-
ity, including content type, fidelity of implementation, inclu-
sion of parents and booster sessions, participant engagement, 
sensitivity of outcome measures and trial quality. We did 
not find an effect of intervention intensity, although all bar 
Fig. 2  Forest plot of effect sizes for comparisons between interven-
tion (CBT or non CBT) and control conditions (waitlist, attention 
control, or no intervention) on post-intervention anxiety symptoms. 
The vertical line indicates the line of no effect, the horizontal lines 
indicates the 95% confidence intervals, and the green dots represent 
the effect estimates from individual studies. Black diamonds indicate 
the pooled results of the studies
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three of our included studies were delivered weekly. Simi-
lar to Neil and Christensen [16], we did not find an effect 
of control group. The absence of an effect of control group 
suggests that the attention control conditions either did not 
impact anxiety outcomes or that there was insufficient evi-
dence to detect a difference. Better attention controls, with 
high therapeutic potential [57], could help to determine 
whether general vs. specific factors have a role in anxiety 
prevention.
We could not conduct a sub-group analysis for age, deliv-
ery agent, or program type as there were too few studies. 
Notably, very few interventions were designed to be deliv-
ered by teachers. This may be because of the challenges 
in training teachers in mental health, compared to mental 
health professionals, for time-limited research studies and/or 
because of the lack of human and other resources available 
in schools for delivery by school staff. Findings on deliv-
ery agents in general are mixed, from no effect in universal 
programs [12], to better outcomes from teacher delivered 
indicated programs for anxiety [16] to better outcomes from 
mental health professionals for depression programs [20, 21, 
58]. Age of participants, complexity of program, delivery 
support and level of teacher experience and understanding 
of anxiety vs depression may explain these outcomes.
This meta-analysis should be reviewed in the context of 
several limitations, including high heterogeneity in study 
design and methodology and poor study quality. Risk of 
contamination and publication bias were high. These limi-
tations are common in trials of all program types [19, 20] 
and high contamination risk suggests that effects may actu-
ally be underestimated. Additionally, most studies relied 
on self-report measures. Although self-report measures 
do not have sufficient sensitivity and specificity to detect 
anxiety disorder [59, 60], studies used validated self-report 
measures that can capture current interfering symptoms, 
and reduction of scores is meaningful [61]. Some studies 
in our review involved children with clinical levels of anxi-
ety; we included these studies as the main study population 
was sub-clinical and the approach was prevention rather 
than treatment. Most studies reported symptom score cut-
offs for inclusion but not upper symptom score cut-offs for 
exclusion, nor ranges of symptoms scores in the sample. 
Whilst sample means show that studies largely targeted 
sub-clinical young people, a minority of young people 
in the reviewed studies met, or would be likely to have 
met, clinical thresholds for disorder. Indicated programs 
may produce even larger effects if only those with high, 
sub-clinical levels of anxiety (rather than mild-moderate) 
were recruited. Thus, it is possible that some of the inter-
ventions were treatment rather than indicated prevention. 
However, in the absence of costly pre-screening for pro-
gram entry, real-world school interventions are likely to 
attract young people with diverse symptoms. Thus, the 
reported ES are likely to be ecologically valid.
Future studies should explore the effects of different pro-
gram intensities and the optimal age for intervention, con-
sidering the most critical and plastic periods of development. 
Although most programs were delivered by MHPs, this is 
unlikely to be a scalable and sustainable solution given 
costs and clinician availability. Teacher burden is already 
high. Evidence from low-and middle-income countries sug-
gests that well-trained lay workers can be effective delivery 
agents of school mental health programs and future studies 
in high-income countries should examine their acceptabil-
ity and effectiveness [62]. Robust assessments of fidelity 
remain infrequent and should be addressed. Whilst digit-
ised delivery of interventions is growing and could pro-
tect fidelity, we need a better understanding of how young 
people engage digitally, independently, and remotely with 
mental health content. It is also unclear if and how parental 
involvement can enhance school-based interventions. Clus-
ter randomisation, attention controls, and detailed descrip-
tions of the allocation sequence generation and concealment 
would help to improve the quality of future trials of school 
indicated programs. Future studies should assess outcomes 
beyond 12 months. As children’s ability to accurately self-
report anxiety symptoms may vary considerably across 
ages, studies should also use multi-informant assessment 
methods [60]. Adolescents may have different rates of diag-
nostic accuracy to younger children, but this has yet to be 
established. Greater use of diagnostic assessments would 
strengthen the emerging evidence that indicated approaches 
can prevent anxiety disorder onset. Pragmatic trials in 
schools are needed to build evidence on implementation, 
sustainability, effectiveness, and cost-effectiveness.
Conclusions
Recommendations for implementing school-based inter-
ventions should be based on the analysis of multiple fac-
tors including intervention cost, the personal and societal 
burden borne by individuals without intervention, and the 
likely ES of an intervention [10]. This review of school-
based indicated programs for reducing symptoms of anxi-
ety in children and adolescents has produced a favourable 
post-test ES that exceeds the estimates produced by others 
for universal prevention programs in schools and in other 
settings for youth internalising problems [11]. Even stronger 
effects were found at 6–12 months, which exceeded many ES 
produced from reviews of universal approaches in school for 
anxiety symptom reduction. However, the small number of 
studies with long-term follow-up data, and the considerable 
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heterogeneity and high risk of bias in the reviewed trials 
means that the findings should be interpreted with caution.
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